Abstract | BACKGROUND: Anti-pneumococcal fluoroquinolone has been used to treat community-acquired pneumonia (CAP) frequently because of its broad antimicrobial spectrum. METHODS: RESULTS: From July 2004 to February 2006, 50 patients were enrolled ( levofloxacin, n = 26; combination therapy, n = 24). The clinical response rate in the clinically evaluable population was similar for both groups (78.3% vs. 77.3%; p = 1.000). Levofloxacin had a higher microbiological response rate overall, and for Gram-negative and non-pseudomonas Gram-negative pathogens than the combination therapy but the difference was not statistically significant (60.0% vs. 38.9%, 55.0% vs. 21.0% and 75.0% vs. 25.0%, respectively). The length of hospital stay was similar for both groups (7.4 +/- 3.1 vs. 6.8 +/- 2.1 days; p = 1.000). CONCLUSION: Patients who were admitted to our hospital for CAP were older and had more comorbidities with a much higher incidence of Gram-negative pathogens than in a previous study. Levofloxacin was at least as effective as amoxicillin/ clavulanate plus clarithromycin in clinical and microbiological responses. Levofloxacin had a higher microbiological eradication rate than the combination therapy but the difference was not statistically significant. This deserves further study with a larer sample size.
|
Authors | Ting-Yu Lin, Shu-Min Lin, Hao-Cheng Chen, Chih-Jan Wang, Yu-Min Wang, Min-Li Chang, Chun-Hua Wang, Chien-Ying Liu, Horng-Chyuan Lin, Chih-Ten Yu, Ling-Ling Hsieh, Han-Pin Kuo, Chien-Da Huang |
Journal | Chang Gung medical journal
(Chang Gung Med J)
2007 Jul-Aug
Vol. 30
Issue 4
Pg. 321-32
ISSN: 2072-0939 [Print] China (Republic : 1949- ) |
PMID | 17939262
(Publication Type: Comparative Study, Journal Article, Randomized Controlled Trial, Research Support, Non-U.S. Gov't)
|
Chemical References |
- Anti-Bacterial Agents
- Levofloxacin
- Amoxicillin-Potassium Clavulanate Combination
- Ofloxacin
|
Topics |
- Adult
- Aged
- Amoxicillin-Potassium Clavulanate Combination
(therapeutic use)
- Anti-Bacterial Agents
(therapeutic use)
- Community-Acquired Infections
(drug therapy, microbiology)
- Female
- Hospitalization
- Humans
- Levofloxacin
- Male
- Middle Aged
- Ofloxacin
(therapeutic use)
- Pneumonia, Bacterial
(drug therapy, microbiology)
|